Thursday , May 2 2024
Home / Real-World Economics Review / The New York Times has not heard of China’s (or Russia’s) vaccines

The New York Times has not heard of China’s (or Russia’s) vaccines

Summary:
From Dean Baker I guess it is hard to get news at the world’s leading newspapers, but this lengthy podcast on Bill Gates and his efforts to make vaccines available to the developing world never once mentioned the vaccines developed by China or Russia. This is more than a bit incredible because at this point, far more of the Russian and Chinese vaccines are going to developing countries than the vaccines supplied by Western countries through COVAX, the international consortium set up the WHO and supported by the Gates Foundation. Are New York Times reporters prohibited from talking about the Chinese and Russian vaccines? This piece is also incredible in that it explicitly says that because Gates doesn’t want the government-granted patent monopoly system of financing from being

Topics:
Dean Baker considers the following as important:

This could be interesting, too:

Eric Kramer writes An economic analysis of presidential immunity

Angry Bear writes Protesting Now and in the Sixties and Seventies

Lars Pålsson Syll writes The non-existence of economic laws

John Quiggin writes The war to end war, still going on

from Dean Baker

I guess it is hard to get news at the world’s leading newspapers, but this lengthy podcast on Bill Gates and his efforts to make vaccines available to the developing world never once mentioned the vaccines developed by China or Russia. This is more than a bit incredible because at this point, far more of the Russian and Chinese vaccines are going to developing countries than the vaccines supplied by Western countries through COVAX, the international consortium set up the WHO and supported by the Gates Foundation.

Are New York Times reporters prohibited from talking about the Chinese and Russian vaccines?

This piece is also incredible in that it explicitly says that because Gates doesn’t want the government-granted patent monopoly system of financing from being challenged, there is no alternative. That could well be true, but it speaks to the incredible corruption of our politics and our economy, that because one incredibly rich person to opposed to having a corrupt, inefficient, and antiquated system reformed, it will not be reformed.

Dean Baker
Dean Baker is a macroeconomist and codirector of the Center for Economic and Policy Research in Washington, DC. He previously worked as a senior economist at the Economic Policy Institute and an assistant professor at Bucknell University. He is a regular Truthout columnist and a member of Truthout's Board of Advisers.

Leave a Reply

Your email address will not be published. Required fields are marked *